Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Boston Scientific Corp Prices $1.05 Billion Of Senior Notes


Thursday, 8 Aug 2013 07:01pm EDT 

Boston Scientific Corp announced the pricing of a public offering of $1.05 billion aggregate principal amount of its senior notes under the Company's shelf registration statement. The public offering consists of $600 million of 2.650% notes due October 1, 2018 and $450 million of 4.125% notes due October 1, 2023. The company expects to receive the net offering proceeds upon closing on August 13, 2013. Boston Scientific intends to use the net proceeds from the offering, together with borrowings under its recent $400 million term loan facility, to redeem all or a portion of its 5.450% notes due June 15, 2014, of which $600 million aggregate principal amount was outstanding as of the date hereof, and 4.500% notes due January 15, 2015, of which $850 million aggregate principal amount was outstanding as of the date hereof, and to pay related fees, expenses and premiums. Any such redemption would be made in accordance with the terms of the applicable indenture, including provision of the required notice of redemption. Any remaining net proceeds from the offering may be used for general corporate purposes. 

Company Quote

13.13
0.07 +0.54%
24 Dec 2014